With mounting evidence on preoperative AFP levels of prognostic interest, it would be relevant to AFP modulate to the therapeutic management strategies of HCC and the BCLC guidelines to improve the treatment of HCC patients [19,20]. This evidence concerns the gene AFP and hepatocellular carcinoma.